Turn Therapeutics (TTRX) Total Current Liabilities (2024 - 2026)

Turn Therapeutics' Total Current Liabilities history runs 3 years deep, the most recent figure standing at $5.1 million for Q1 2026.

• In Q1 2026, Total Current Liabilities changed N/A year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $5.1 million (changed N/A YoY), while the FY2025 annual figure was $6.0 million, up 748.02% from the prior year.
• Total Current Liabilities was $5.1 million for Q1 2026 at Turn Therapeutics, down from $6.0 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $6.0 million in Q4 2025 to a low of $707932.0 in Q4 2024.
• Historically, Total Current Liabilities has averaged $3.5 million across 3 years, with a median of $3.7 million in 2025.
• Biggest YoY gain for Total Current Liabilities was 748.02% in 2025; the steepest drop was 748.02% in 2025.
• A 3-year view of Total Current Liabilities shows it stood at $707932.0 in 2024, then surged by 748.02% to $6.0 million in 2025, then retreated by 14.54% to $5.1 million in 2026.
• The last three Total Current Liabilities figures came in at $5.1 million (Q1 2026), $6.0 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.